Clinical trials
Phase 1 Neoplasms by Site trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 9 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 3 |
| Revolution Medicines, Inc. | 3 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Advanced Accelerator Applications | 1 |
| Advaxis, Inc. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Aragon Pharmaceuticals, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 32 |
| Neoplasms | 30 |
| Lung Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Lung Diseases | 10 |
| Thoracic Neoplasms | 10 |
| Carcinoma, Bronchogenic | 8 |
| Neoplasms by Histologic Type | 8 |
| Respiratory Tract Diseases | 8 |
| Respiratory Tract Neoplasms | 8 |
Trials
Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.